ReleaseWire Connect

Schizophrenia - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Schizophrenia in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Primary Biliary Cholangitis (PBC) - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Primary Biliary Cholangitis (PBC) in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Portal Hypertension- Pipeline Insights, 2018 report outlays comprehensive insights of present scenario and growth prospects across Portal Hypertension. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 3+ active products along with 3+ companies involved. Cumberland Pharmaceuticals and Conatus Pharmaceuticals are among the major drug developers as per the current pipeline scenario.

Pompe Disease - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Pompe Disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Peridontal Disease - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Peridontal Disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Pancreatic Cancer in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Oncolytic Virus Cancer Therapy- Pipeline Insights, 2018 report outlays comprehensive insights of present scenario and growth prospects across Oncolytic Virus Cancer Therapy. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 65+ products with more than 25 companies involved. Some of the emerging products include Pexa-Vec of Transgene/SillaJen, Telomelsin of Oncolys, and Canerpaturev (TBI-1401) of Takara Bio.

Fatty Acid Amide Hydrolase (FAAH) Inhibitors- Pipeline Insights, 2018 report outlays comprehensive insights of present scenario and growth prospects across Fatty Acid Amide Hydrolase (FAAH) Inhibitor. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 5+ active products with more than 5 companies involved. Two of the key players include PF-04457845 of Spring Works Therapeutics and JNJ-42165279 of Janssen.

Dendritic Cancer Cell Therapy- Pipeline Insights, 2018 report outlays comprehensive insights of present scenario and growth prospects across Dendritic Cancer Cell Therapy. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 25+ products with more than 15+ companies involved. Some of the emerging products include DCVax-L of Northwest Biotherapeutics, CreaVax of Creagene, and Rocapuldencel-T of Argos Therapeutics.